50% off Premium Yearly
Canntrust Holdings Inc.TRST.TOTOP PICKOct 17, 2018Stock price when the opinion was issued
As of May 06, 2020. Market Open.
This is a relatively small cannabis player but the trailing EBITDA is minimal and the forecasted earnings are speculative. He bought the IPO at $2 and sold it at $4. It’s one of the higher quality companies in the space, with interesting value add ideas. They even have a patent for infused cannabis in Keurig cups.
This company was founded by pharmacists who is globally focused in generic drug manufacturing in 115 countries. They win 38% of new patients added to new medical cannabis users. They hire doctors to educate doctors about medical usages. Yield 0%. (Analysts’ price target is $16.93)